On April 17, 2026, OpenAI unveiled a new artificial intelligence tool designed to accelerate the drug discovery process.
This initiative marks a significant move by OpenAI as it seeks to challenge Google's established presence in the field.
The development highlights the growing importance of AI in pharmaceutical research and the competitive landscape among tech giants.